The peroxynitrite decomposition catalyst FP15 improves ageing-associated cardiac and vascular dysfunction

Mechanisms of Ageing and Development

Volumn 128, Issue 2, 2007, Pages 173-181

  Radovits, Tamás ^a   Seres, Leila ^a   Gero, Domokos ^b   Lin, Li ni ^a   Beller, Carsten J ^a   Chen, Song He ^a   Zotkina, Julia ^a   Berger, Irina ^a   Groves, John T ^c   Szabó, Csaba ^b   Szabó, Gábor ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c PRINCETON UNIVERSITY   (United States)

Author keywords

Ageing; Endothelial function; Nitro oxidative stress; Peroxynitrite; Ventricular function

Indexed keywords

ACETYLCHOLINE; FP 15; FP15; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITROPRUSSIDE SODIUM; PEROXYNITRITE; PORPHYRIN DERIVATIVE; UNCLASSIFIED DRUG;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA WALL; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CATHETER; CONTROLLED STUDY; DIASTOLE; ENDOTHELIUM; HEART DISEASE; HEART PERFORMANCE; IMMUNOHISTOCHEMISTRY; MALE; NITROSATIVE STRESS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SYSTOLE; VASCULAR DISEASE; VASCULAR RING; VASODILATATION;

ACETYLCHOLINE; AGING; ANIMALS; AORTA; DIASTOLE; ENDOTHELIUM, VASCULAR; HEART DISEASES; MALE; METALLOPORPHYRINS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, INBRED STRAINS; TYROSINE; VASODILATION; VENTRICULAR FUNCTION, LEFT;

ANIMALIA; RATTUS;

EID: 33846250408     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2006.09.005     Document Type: Article

References (40)

1. Anversa P., Puntillo E., Nikitin P., Olivetti G., Capasso J.M., and Sonnenblick E.H. Effects of age on mechanical and structural properties of myocardium of Fischer 344 rats. Am. J. Physiol. 256 (1989) H1440-H1449
2. Bejma J., Ramires P., and Ji L.L. Free radical generation and oxidative stress with ageing and exercise: differential effects in the myocardium and liver. Acta Physiol. Scand. 169 (2000) 343-351
3. Boluyt M.O., Converso K., Hwang H.S., Mikkor A., and Russell M.W. Echocardiographic assessment of age-associated changes in systolic and diastolic function of the female F344 rat heart. J. Appl. Physiol. 96 (2004) 822-828
4. Capasso J.M., Palackal T., Olivetti G., and Anversa P. Severe myocardial dysfunction induced by ventricular remodeling in aging rat hearts. Am. J. Physiol. 259 (1990) H1086-H1096
5. Csiszar A., Pacher P., Kaley G., and Ungvari Z. Role of oxidative and nitrosative stress, longevity genes and poly(ADP-ribose) polymerase in cardiovascular dysfunction associated with aging. Curr. Vasc. Pharmacol. 3 (2005) 285-291
6. Csiszar A., Ungvari Z., Edwards J.G., Kaminski P., Wolin M.S., Koller A., and Kaley G. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ. Res. 90 (2002) 1159-1166
7. de la Asuncion J.G., Millan A., Pla R., Bruseghini L., Esteras A., Pallardo F.V., Sastre J., and Vina J. Mitochondrial glutathione oxidation correlates with age-associated oxidative damage to mitochondrial DNA. FASEB J. 10 (1996) 333-338
8. Egashira K., Inou T., Hirooka Y., Kai H., Sugimachi M., Suzuki S., Kuga T., Urabe Y., and Takeshita A. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 88 (1993) 77-81
9. Gross M.L., Ritz E., Korsch M., Adamczak M., Weckbach M., Mall G., Berger I., Hansen A., and Amann K. Effects of estrogens on cardiovascular structure in uninephrectomized SHRsp rats. Kidney Int. 67 (2005) 849-857
10. Hachamovitch R., Wicker P., Capasso J.M., and Anversa P. Alterations of coronary blood flow and reserve with aging in Fischer 344 rats. Am. J. Physiol. 256 (1989) H66-H73
11. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo?. FEBS Lett. 411 (1997) 157-160
12. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11 (1956) 298-300
13. Kim J.D., Mccarter R.J., and Yu B.P. Influence of age, exercise, and dietary restriction on oxidative stress in rats. Aging (Milano) 8 (1996) 123-129
14. Liaudet L., Soriano F.G., Szabo E., Virag L., Mabley J.G., Salzman A.L., and Szabo C. Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 10203-10208
15. Nohl H., Breuninger V., and Hegner D. Influence of mitochondrial radical formation on energy-linked respiration. Eur. J. Biochem. 90 (1978) 385-390
16. Pacher P., Cziraki A., Mabley J.G., Liaudet L., Papp L., and Szabo C. Role of poly(ADP-ribose) polymerase activation in endotoxin-induced cardiac collapse in rodents. Biochem. Pharmacol. 64 (2002) 1785-1791
17. Pacher P., Liaudet L., Bai P., Mabley J.G., Kaminski P.M., Virag L., Deb A., Szabo E., Ungvari Z., Wolin M.S., Groves J.T., and Szabo C. Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation 107 (2003) 896-904
18. Pacher P., Liaudet L., Bai P., Virag L., Mabley J.G., Hasko G., and Szabo C. Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure. J. Pharmacol. Exp. Ther. 300 (2002) 862-867
19. Pacher P., Liaudet L., Mabley J.G., Cziraki A., Hasko G., and Szabo C. Beneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure. Int. J. Mol. Med. 17 (2006) 369-375
20. Pacher P., Liaudet L., Mabley J., Komjati K., and Szabo C. Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure. J. Am. Coll. Cardiol. 40 (2002) 1006-1016
21. Pacher P., Liaudet L., Soriano F.G., Mabley J.G., Szabo E., and Szabo C. The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51 (2002) 514-521
22. Pacher P., Mabley J.G., Liaudet L., Evgenov O.V., Marton A., Hasko G., Kollai M., and Szabo C. Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure. Am. J. Physiol. Heart. Circ. Physiol. 287 (2004) H2132-H2137
23. Pacher P., Mabley J.G., Soriano F.G., Liaudet L., Komjati K., and Szabo C. Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation. Br. J. Pharmacol. 135 (2002) 1347-1350
24. Pacher P., Mabley J.G., Soriano F.G., Liaudet L., and Szabo C. Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging. Int. J. Mol. Med. 9 (2002) 659-664
25. Pacher P., Schulz R., Liaudet L., and Szabo C. Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol. Sci. 26 (2005) 302-310
26. Pacher P., Vaslin A., Benko R., Mabley J.G., Liaudet L., Hasko G., Marton A., Batkai S., Kollai M., and Szabo C. A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging. J. Pharmacol. Exp. Ther. 311 (2004) 485-491
27. Pieper G.M., Nilakantan V., Chen M., Zhou J., Khanna A.K., Henderson Jr. J.D., Johnson C.P., Roza A.M., and Szabo C. Protective mechanisms of a metalloporphyrinic peroxynitrite decomposition catalyst, WW85, in rat cardiac transplants. J. Pharmacol. Exp. Ther. 314 (2005) 53-60
28. Sohal R.S., and Sohal B.H. Hydrogen peroxide release by mitochondria increases during aging. Mech. Age. Dev. 57 (1991) 187-202
29. Soriano F.G., Pacher P., Mabley J., Liaudet L., and Szabo C. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase. Circ. Res. 89 (2001) 684-691
30. Soriano F.G., Virag L., and Szabo C. Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation. J. Mol. Med. 79 (2001) 437-448
31. Szabo C., Cuzzocrea S., Zingarelli B., O'connor M., and Salzman A.L. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J. Clin. Invest. 100 (1997) 723-735
32. Szabo C., Mabley J.G., Moeller S.M., Shimanovich R., Pacher P., Virag L., Soriano F.G., Van Duzer J.H., Williams W., Salzman A.L., and Groves J.T. FP 15, a novel potent peroxynitrite decomposition catalyst: in vitro cytoprotective actions and protection against diabetes mellitus and diabetic cardiovascular complications. Mol. Med. 8 (2002) 571-580
33. Szabo G., and Bahrle S. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury. Curr. Vasc. Pharmacol. 3 (2005) 215-220
34. Szabo G., Buhmann V., Andrasi T., Stumpf N., Bahrle S., Kekesi V., Hagl S., Szabo C., and Juhasz-nagy A. Poly-ADP-ribose polymerase inhibition protects against myocardial and endothelial reperfusion injury after hypothermic cardiac arrest. J. Thorac. Cardiovasc. Surg. 126 (2003) 651-658
35. Szabo G., Liaudet L., Hagl S., and Szabo C. Poly(ADP-ribose) polymerase activation in the reperfused myocardium. Cardiovasc. Res. 61 (2004) 471-480
36. Szabo G., Soos P., Mandera S., Heger U., Flechtenmacher C., Bahrle S., Seres L., Cziraki A., Gries A., Zsengeller Z., Vahl C.F., Hagl S., and Szabo C. INO-1001 a novel poly(ADP-ribose) polymerase (PARP) inhibitor improves cardiac and pulmonary function after crystalloid cardioplegia and extracorporal circulation. Shock 21 (2004) 426-432
37. Tschudi M.R., Barton M., Bersinger N.A., Moreau P., Cosentino F., Noll G., Malinski T., and Luscher T.F. Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J. Clin. Invest. 98 (1996) 899-905
38. Van Der Loo B., Labugger R., Skepper J.N., Bachschmid M., Kilo J., Powell J.M., Palacios-callender M., Erusalimsky J.D., Quaschning T., Malinski T., Gygi D., Ullrich V., and Luscher T.F. Enhanced peroxynitrite formation is associated with vascular aging. J. Exp. Med. 192 (2000) 1731-1744
39. Virag L., and Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev. 54 (2002) 375-429
40. Xiao C.Y., Chen M., Zsengeller Z., and Szabo C. Poly(ADP-ribose) polymerase contributes to the development of myocardial infarction in diabetic rats and regulates the nuclear translocation of apoptosis-inducing factor. J. Pharmacol. Exp. Ther. 310 (2004) 498-504